Clearwater Analytics Announces Fourth Quarter and Full Year 2024 Financial Results

Rhea-AI Summary

Clearwater Analytics (NYSE: CWAN) reported strong Q4 2024 results with record quarterly revenue of $126.5 million, up 28% year-over-year. The company achieved an Annualized Recurring Revenue (ARR) of $474.9 million, marking a 25% increase, and a net revenue retention rate of 116%.

Key financial highlights include net income of $420.3 million (including a one-time $472 million tax benefit) and Adjusted EBITDA of $41.7 million, up 39% year-over-year. The company processes $8.8 trillion in assets daily, up from $7.3 trillion in 2023.

Notably, Clearwater announced plans to acquire Enfusion for $1.5 billion, aiming to create the first cloud-native front-to-back platform for investment management. The company expanded its client base to 1,462, with 100 clients contributing at least $1.0 million in ARR.

Positive

• Record quarterly revenue of $126.5M, up 28% YoY
• Net revenue retention rate increased to 116% from 107% YoY
• Adjusted EBITDA grew 39% YoY to $41.7M
• Assets under management increased to $8.8T from $7.3T YoY
• Number of $1M+ ARR clients grew 16.3% to 100
• Strategic acquisition of Enfusion announced for $1.5B

Negative

• Negative operating cash flow of $28.9M in Q4
• One-time settlement payments of $79M impacting cash flow
• Total debt of $45.9M as of December 31, 2024

Insights

Financial Analyst

Clearwater Analytics' Q4 2024 results demonstrate remarkable execution across all key performance metrics, with several indicators exceeding the company's Investor Day targets ahead of schedule. The 27.7% revenue growth to $126.5 million and 116% net revenue retention rate reflect strong market position and successful land-and-expand strategy.

The operational excellence is evident in the 190 basis point improvement in non-GAAP gross margins to 78.8% and 39% growth in adjusted EBITDA to $41.7 million. This margin expansion demonstrates successful scaling of the platform and improving operational leverage. The growth in clients contributing $1M+ in ARR to 100 (up 16.3% YoY) indicates strong penetration in the enterprise segment.

The $1.5 billion Enfusion acquisition marks a transformative moment, positioning Clearwater to offer an integrated front-to-back investment management platform. This strategic move addresses the growing demand for unified investment solutions and expands the total addressable market significantly. The combination will create a unique cloud-native platform covering the entire investment lifecycle, potentially accelerating growth through cross-selling opportunities.

The company's strong balance sheet with $285.8 million in cash and only $45.9 million in debt provides flexibility for continued investments in R&D and international expansion. The negative operating cash flow of $28.9 million was primarily due to one-time TRA settlement payments of $79 million, masking the underlying strong cash generation capability.

The strategic focus on international markets, particularly Europe and Asia, coupled with investments in Generative AI, positions Clearwater well for sustained growth. The expansion of AUM processed on the platform to $8.8 trillion (up from $7.3 trillion) demonstrates increasing market share and platform scalability.

Record Quarterly Revenue of $126.5 Million, Up 28% Year-Over-Year

Annualized Recurring Revenue of $474.9 Million, Up 25% Year-Over-Year

Net Revenue Retention Rate of 116%

Net Income of $420.3 Million

Adjusted EBITDA of $41.7 Million, Up 39% Year-Over-Year

BOISE, Idaho--(BUSINESS WIRE)-- Clearwater Analytics Holdings, Inc. (NYSE: CWAN) (“Clearwater Analytics” or the “Company”), a leading worldwide provider of SaaS-based investment management, accounting, reporting, and analytics solutions, today announced its financial results for the quarter ended December 31, 2024.

	Fourth Quarter 2024		Full Year 2024
Revenue	$126.5 million		$451.8 million
Year-over-Year Revenue Growth %	27.7%		22.7%
Annualized Recurring Revenue (ARR)1			$474.9 million
Year-over-Year ARR Growth %			25.3%
Net Income	$420.3 million		$427.6 million
Net Income Margin %	332.3%		94.6%
Adjusted EBITDA	$41.7 million		$145.7 million
Adjusted EBITDA Margin %	33.0%		32.2%

1ARR is a point in time metric, therefore fourth quarter 2024 and full year 2024 results are the same.

“Q4 2024 has been nothing short of extraordinary for Clearwater Analytics, as we achieved record revenue of $126.5 million and a record net revenue retention rate of 116%. Non-GAAP gross margin grew 170 bps for the year and adjusted EBITDA grew 350 bps for the year. All these metrics are entirely consistent with our plans and the expectations we set during our Investor Day – our execution has allowed us to meet and exceed those goals meaningfully earlier than forecast. These results reflect the effectiveness of our strategies and the relentless dedication of our team, who consistently exceed our clients’ evolving expectations. We continue to invest aggressively in R&D, including Generative AI, to stay ahead of the market and deliver impactful solutions that our clients value. We continue to see significant growth opportunities in both new logo and back-to-base sales in North America and the international markets, particularly in Europe and Asia, where our expertise and technology position us for expansion. We’re confident that our scalable platform will adeptly meet the rising demand from asset owners and managers in these regions,” said Sandeep Sahai, CEO at Clearwater Analytics. “Our announced acquisition of Enfusion is a game changer. This pivotal milestone will broaden our horizons for growth and allow us to extend additional products to our current clients, while enabling us to offer a comprehensive front-to-back platform that will cover the entire investment lifecycle. We’re scaling with a clear vision, excited about our journey, and committed to delivering exceptional value to our clients, employees, and shareholders.”

Fourth Quarter 2024 Financial Results Summary

• Revenue: Total revenue for the fourth quarter of 2024 was $126.5 million, an increase of 27.7%, from $99.0 million in the fourth quarter of 2023.

• Gross Profit: Gross profit for the fourth quarter of 2024 increased to $92.9 million, which equates to a 73.5% GAAP gross margin, compared with gross profit of $70.7 million and GAAP gross margin of 71.4% in the fourth quarter of 2023. Non-GAAP gross profit for the fourth quarter of 2024 was $99.7 million, which equates to a 78.8% non-GAAP gross margin and an increase of 190 basis points over the fourth quarter of 2023.

• Net Income/(Loss): Net income for the fourth quarter of 2024 was $420.3 million, compared with net loss of $3.4 million in the fourth quarter of 2023. Due to the release of our Deferred Tax Asset Valuation Allowance in the fourth quarter of 2024, we recorded deferred tax assets on our balance sheet, which resulted in a one-time income tax benefit in our income statement of $472 million.

• Adjusted EBITDA: Adjusted EBITDA for the fourth quarter of 2024 was $41.7 million, an increase of 39.0%, from $30.0 million in the fourth quarter of 2023. Adjusted EBITDA margin for the fourth quarter of 2024 was 33.0%, an increase of 270 basis points over the fourth quarter of 2023.

• Cash Flows: Operating cash flows for the fourth quarter of 2024 were negative $28.9 million. Cash flows in the fourth quarter of 2024 were impacted by the one-time settlement payments relating to the termination of the Company's Tax Receivable Agreement and associated fees of $79 million in the fourth quarter of 2024.

• Earnings Per Share and Non-GAAP Net Income Per Share attributable to Clearwater Analytics Holdings, Inc.: Earnings per basic share was $1.85, and earnings per diluted share was $1.63 in the fourth quarter of 2024. Non-GAAP net income per basic share was $0.15, and non-GAAP net income per diluted share was $0.13 in the fourth quarter of 2024.

• Cash, cash equivalents, and investments were $285.8 million as of December 31, 2024. Total debt, net of debt issuance cost, was $45.9 million as of December 31, 2024.

Fourth Quarter 2024 Key Metrics Summary

• Annualized Recurring Revenue: As of December 31, 2024, annualized recurring revenue (“ARR”) reached $474.9 million, an increase of 25.3% from $379.1 million as of December 31, 2023.
  
  ARR is calculated at the end of a period by dividing the recurring revenue in the last month of such period by the number of days in the month and multiplying by 365.

• Gross Revenue Retention Rate: As of December 31, 2024, the gross revenue retention rate was 98%, compared to 98% as of December 31, 2023.
  
  Gross revenue retention rate represents annual contract value (“ACV”) at the beginning of the 12-month period ended on the reporting date less client attrition over the prior 12-month period, divided by ACV at the beginning of the 12-month period, expressed as a percentage. ACV is comprised of annualized recurring revenue plus contracted-not-billed revenue, which represents the estimated annual contracted revenue for new and existing client opportunities prior to revenue recognition.

• Net Revenue Retention Rate: As of December 31, 2024, the net revenue retention rate was 116%, compared to 114% as of September 30, 2024 and to 107% as of December 31, 2023.
  
  Net revenue retention rate is the percentage of recurring revenue from clients on the platform for 12 months and includes changes from the addition, removal, or value of assets on our platform, contractual changes that have an impact to annualized recurring revenues and lost revenue from client attrition.

• Clients: As of December 31, 2024, the Company had 1,462 clients, including 100 clients that contributed at least $1.0 million in ARR, an increase of 16.3% from 86 clients that contributed at least $1.0 million in ARR as of December 31, 2023.

• Assets Under Management (AUM): As of December 31, 2024, the platform processes and reports on $8.8 trillion assets daily, compared to $7.3 trillion assets daily as of December 31, 2023.

Recent Business Highlights

• On January 13, 2025, Clearwater Analytics announced its intent to acquire Enfusion, Inc. a leader in software-as-a-service (SaaS) solutions for the investment management and hedge fund industry, for $1.5 billion, expanding its investment management platform with front-to-back capabilities. The acquisition of Enfusion accelerates Clearwater’s vision of building the first cloud-native front-to-back platform for the entire investment management industry.

• In the fourth quarter, the Company expanded its footprint within existing clients and added marquee clients such as Imperial Fund Capital Partners, Invictus Capital Management, National Association of Realtors, Nucor Corporation, OpenAI, School Employees Retirement System of Ohio, State of Louisiana, United Nations Federal Credit Union, Vaxcyte, and WCF Insurance.

• The Company announced that Industrial Alliance Portfolio Management (“IAPM”) selected Clearwater Analytics to enhance its performance attribution and risk analysis capabilities. IAPM is using the Clearwater Analytics Risk & Performance Solution to perform in-depth factor-based attribution and ex-ante risk analyses.

• The Company announced that The Alameda County Employees’ Retirement Association (“ACERA”) selected Clearwater Analytics to provide data validation, shadow book of record accounting, and total plan reporting across its entire investment portfolio, including its alternative assets. ACERA will leverage the Clearwater platform with embedded Generative AI capabilities to automatically aggregate and validate data across multiple sources and formats and identify and escalate data anomalies or failures.

First Quarter and Full Year 2025 Guidance

	First Quarter 2025		Full Year 2025
Revenue	$125 million		$535.5 million to $542 million
Year-over-Year Growth %	~22%		~19% to 20%
Adjusted EBITDA	$41.5 million		$182 million to $185 million
Adjusted EBITDA Margin %	~33%		~34%
Total equity-based compensation expense and related payroll taxes			~$106 million
Depreciation and Amortization			~$13 million
Non-GAAP effective tax rate			25%
Diluted non-GAAP share count			~263 million
*This guidance assumes no effect from the proposed Enfusion acquisition.

Certain components of the guidance given above are provided on a non-GAAP basis only without providing a reconciliation to guidance provided on a GAAP basis. Information is presented in this manner because the preparation of such a reconciliation could not be accomplished without “unreasonable efforts.” The Company does not have access to certain information that would be necessary to provide such a reconciliation, including non-recurring items that are not indicative of the Company’s ongoing operations. The Company does not believe that this information is likely to be significant to an assessment of the Company’s ongoing operations.

Conference Call Details

Clearwater Analytics will hold a conference call and webcast on February 19, 2025, at 5:00 p.m. Eastern time to discuss fourth quarter and full year 2024 financial results, provide a general business update, and respond to analyst questions.

A live webcast of the call will also be available on the Company’s investor relations website. Please visit investors.clearwateranalytics.com at least fifteen minutes prior to the start of the event to register, download and install any necessary audio software.

If you are unable to participate live, a replay of the webcast will be available following the conference call on the Company’s investor relations website, along with the earnings press release, and related financial tables.

About Clearwater Analytics

Clearwater Analytics (NYSE: CWAN), a global, industry-leading SaaS solution, automates the entire investment lifecycle. With a single instance, multi-tenant architecture, Clearwater offers award-winning investment portfolio planning, performance reporting, data aggregation, reconciliation, accounting, compliance, risk, and order management. Each day, leading insurers, asset managers, corporations, and governments use Clearwater’s trusted data to drive efficient, scalable investing on more than $8.8 trillion in assets spanning traditional and alternative asset types. Additional information about Clearwater can be found at clearwateranalytics.com.

Use of non-GAAP Information

This press release contains certain non-GAAP measures, including non-GAAP gross profit, non-GAAP gross margin, adjusted EBITDA, adjusted EBITDA margin, non-GAAP net income, non-GAAP net income per basic and diluted share, non-GAAP effective tax rate, diluted non-GAAP share count and free cash flow.

The non-GAAP measures are not based on any standardized methodology prescribed by GAAP and are not necessarily comparable to similar measures presented by other companies. However, the Company believes that this non-GAAP information is useful as an additional means for investors to evaluate its operating performance, when reviewed in conjunction with its GAAP financial statements. These measures should not be considered in isolation or as a substitute for measures prepared in accordance with GAAP, and because these amounts are not determined in accordance with GAAP, they should not be used exclusively in evaluating the Company's business and operations. In addition, undue reliance should not be placed upon non-GAAP or operating information because this information is neither standardized across companies nor subjected to the same control activities and audit procedures that produce the Company's GAAP financial results.

The Company's non-GAAP statement of operations measures, including non-GAAP gross profit, non-GAAP gross margin, adjusted EBITDA, adjusted EBITDA margin, non-GAAP net income, non-GAAP net income per basic and diluted share, non-GAAP effective tax rate, diluted non-GAAP share count and free cash flow, are adjusted to exclude the impact of certain costs, expenses, gains and losses and other specified items that management believes are not indicative of its ongoing operations. These adjusted measures exclude the impact of share-based compensation and eliminate potential differences in results of operations between periods caused by factors such as financing and capital structures, taxation positions or regimes, restructuring, transaction expenses, impairment and other charges. Please refer to the reconciliations of these measures below to what the Company believes are the most directly comparable measures evaluated in accordance with GAAP.

Use of Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management’s beliefs and assumptions and on information currently available to management. Forward-looking statements include information concerning the timing of the consummation of acquisition of Enfusion and the ability to satisfy closing conditions, the Company's possible or assumed future results of operations, business strategies, technology developments, financing and investment plans, dividend policy, competitive position, industry, economic and regulatory environment, potential growth opportunities and the effects of competition. Forward-looking statements include statements that are not historical facts and can be identified by terms such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “aim,” “may,” “plan,” “potential,” “predict,” “project,” “seek,” “should,” “will,” “would” or similar expressions and the negatives of those terms, but are not the exclusive means of identifying such statements.

Forward-looking statements involve known and unknown risks, uncertainties, and other factors, many of which are beyond the Company’s control, that may cause the Company’s actual results, performance, or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. These risks and uncertainties may cause actual results to differ materially from Clearwater Analytics’ current expectations and include, but are not limited to, the Company’s ability to successfully close the acquisition of Enfusion, the Company’s ability to successfully integrate the operations and technology of Enfusion with those of the Company, retain and incentivize the employees of Enfusion following the close of the acquisition, retain Enfusion’s clients, repay debt to be incurred in connection with the Enfusion acquisition and meet financial covenants to be imposed in connection with such debt, risks that cost savings, synergies and growth from the proposed Enfusion acquisition may not be fully realized or may take longer to realize than expected, the Company's ability to keep pace with rapid technological change and market developments, including artificial intelligence, competitors in its industry, the possibility that market volatility, a downturn in economic conditions or other factors may cause negative trends or fluctuations in the value of the assets on the Company’s platform, the Company's ability to manage growth, the Company's ability to attract and retain skilled employees, the possibility that the Company's solutions fail to perform properly, disruptions and failures in the Company's and third parties’ computer equipment, cloud-based services, electronic delivery systems, networks and telecommunications systems and infrastructure, the failure to protect the Company, its customers’ and/or its vendors’ confidential information and/or intellectual property, claims of infringement of others’ intellectual property, factors related to the Company's ownership structure as well as other risks and uncertainties detailed in Clearwater Analytics’ periodic public filings with the U.S. Securities and Exchange Commission (the “SEC”), including but not limited to those discussed under “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 filed with the SEC on February 29, 2024, those discussed under “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 that will be filed following this earnings release, and in other periodic reports the Company subsequently files with the SEC. These filings are available at www.sec.gov and on the Company’s website. Given these uncertainties, you should not place undue reliance on forward-looking statements. Also, forward-looking statements represent management’s beliefs and assumptions only as of the date of this press release and should not be relied upon as representing the Company’s expectations or beliefs as of any date subsequent to the time they are made. The Company does not undertake to and specifically declines any obligation to update any forward-looking statements that may be made from time to time by or on behalf of the Company.

Clearwater Analytics Holdings, Inc. Consolidated Balance Sheets (In thousands, except share amounts and per share amounts, unaudited)
	December 31,				December 31,
		2024				2023
Assets
Current assets:
Cash and cash equivalents	$	177,350			$	221,765
Short-term investments		78,139				74,457
Accounts receivable, net		106,151				92,091
Prepaid expenses and other current assets		23,006				27,683
Total current assets		384,646				415,996
Property and equipment, net		14,797				15,349
Operating lease right-of-use assets, net		24,797				22,554
Deferred contract costs, non-current		7,013				6,439
Debt issuance costs - line of credit		339				533
Deferred tax assets, net		602,500				1,344
Other non-current assets		3,340				3,563
Intangible assets, net		30,868				26,132
Goodwill		70,971				45,338
Long-term investments		30,301				21,495
Total assets	$	1,169,572			$	558,743
Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable	$	2,934			$	3,062
Accrued expenses and other current liabilities		62,983				49,535
Notes payable, current portion		2,750				2,750
Operating lease liability, current portion		8,350				6,551
Tax receivable agreement liability		35				18,894
Total current liabilities		77,052				80,792
Notes payable, less current maturities and unamortized debt issuance costs		43,164				45,828
Operating lease liability, less current portion		17,655				16,948
Other long-term liabilities		1,470				5,518
Total liabilities		139,341				149,086
Commitments and contingencies (Note 11)
Stockholders' Equity
Class A common stock, par value $0.001 per share; 1,500,000,000 shares authorized, 212,857,580 shares issued and outstanding as of December 31, 2024, 127,604,185 shares issued and outstanding as of December 31, 2023		213				128
Class B common stock, par value $0.001 per share; 500,000,000 shares authorized, no share issued and outstanding as of December 31, 2024, 111,191 shares issued and outstanding as of December 31, 2023		—				—
Class C common stock, par value $0.001 per share; 500,000,000 shares authorized, 12,542,110 shares issued and outstanding as of December 31, 2024, 32,684,156 shares issued and outstanding as of December 31, 2023		13				33
Class D common stock, par value $0.001 per share; 500,000,000 shares authorized, 22,243,668 shares issued and outstanding as of December 31, 2024, 82,955,977 shares issued and outstanding as of December 31, 2023		22				83
Additional paid-in-capital		725,174				532,507
Accumulated other comprehensive (loss) income		(1,113	)			2,909
Retained earnings (accumulated deficit)		283,946				(181,331	)
Total stockholders' equity attributable to Clearwater Analytics Holdings, Inc.		1,008,255				354,329
Non-controlling interests		21,976				55,328
Total stockholders' equity		1,030,231				409,657
Total liabilities and stockholders' equity	$	1,169,572			$	558,743

Clearwater Analytics Holdings, Inc. Consolidated Statements of Operations (In thousands, except share amounts and per share amounts, unaudited)
	Three Months Ended December 31,								Year Ended December 31,
		2024				2023				2024				2023
Revenue	$	126,465			$	99,019			$	451,803			$	368,168
Cost of revenue(1)		33,561				28,335				122,987				107,127
Gross profit		92,904				70,684				328,816				261,041
Operating expenses:
Research and development(1)		40,904				33,728				150,558				123,925
Sales and marketing(1)		17,885				16,316				67,254				60,365
General and administrative(1)		32,896				18,050				98,770				93,496
Total operating expenses		91,685				68,094				316,582				277,786
Income (loss) from operations		1,219				2,590				12,234				(16,745	)
Interest income, net		(2,430	)			(1,979	)			(8,621	)			(6,401	)
Tax receivable agreement expense		41,637				8,284				53,181				14,396
Other income, net		(1,150	)			(669	)			(2,263	)			(1,874	)
Loss before income taxes		(36,838	)			(3,046	)			(30,063	)			(22,866	)
Provision for (benefit from) income taxes		(457,143	)			401				(457,648	)			217
Net income (loss)		420,305				(3,447	)			427,585				(23,083	)
Less: Net income (loss) attributable to non-controlling interests		819				739				3,207				(1,456	)
Net income (loss) attributable to Clearwater Analytics Holdings, Inc.	$	419,486			$	(4,186	)		$	424,378			$	(21,627	)
Net earnings (loss) per share attributable to Class A and Class D common stock:
Basic	$	1.85			$	(0.02	)		$	1.93			$	(0.11	)
Diluted	$	1.63			$	(0.02	)		$	1.68			$	(0.11	)
Weighted average shares of Class A and Class D common stock outstanding:
Basic		226,571,994				206,193,802				219,316,625				199,691,873
Diluted		258,131,701				206,193,802				254,362,539				199,691,873

(1) Amounts include equity-based compensation as follows:

Cost of revenue	$	3,755		$	3,378		$	13,634		$	12,215
Operating expenses:
Research and development		9,326			7,346			36,093			24,739
Sales and marketing		4,885			4,622			15,304			15,843
General and administrative		10,176			6,975			38,170			51,650
Total equity-based compensation expense	$	28,142		$	22,321		$	103,201		$	104,447

Clearwater Analytics Holdings, Inc. Consolidated Statements of Cash Flows (In thousands, unaudited)
	Three Months Ended December 31,								Year Ended December 31,
		2024				2023				2024				2023
OPERATING ACTIVITIES
Net income (loss)	$	420,305			$	(3,447	)		$	427,585			$	(23,083	)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization		3,451				2,593				12,181				9,929
Noncash operating lease cost		2,341				1,952				9,221				7,619
Equity-based compensation		28,142				22,321				103,201				104,447
Amortization of deferred contract acquisition costs		1,692				1,200				5,265				4,763
Amortization of debt issuance costs, included in interest expense		71				71				280				280
Accretion of discount on investments		(452	)			(573	)			(2,185	)			(1,474	)
Deferred tax benefit		(456,956	)			(913	)			(460,032	)			(1,665	)
Realized gain on investments		—				—				(35	)			(89	)
Loss on fixed assets disposal		66				—				66				—
Changes in operating assets and liabilities, excluding the impact of business acquisitions:
Accounts receivable, net		(5,774	)			(434	)			(13,648	)			(19,298	)
Prepaid expenses and other assets		3,066				(3,068	)			5,627				1,151
Deferred contract acquisition costs		(2,826	)			(2,405	)			(6,242	)			(5,067	)
Accounts payable		(1,317	)			(224	)			269				(115	)
Accrued expenses and other liabilities		8,044				7,081				11,627				1,204
Tax receivable agreement liability		(28,793	)			(61	)			(18,859	)			6,000
Net cash (used in) provided by operating activities		(28,940	)			24,093				74,321				84,602
INVESTING ACTIVITIES
Purchases of property and equipment		(822	)			(1,562	)			(5,259	)			(5,624	)
Purchase of held to maturity investments		—				—				(3,009	)			(3,004	)
Purchases of available-for-sale investments		(20,662	)			(13,160	)			(114,572	)			(124,178	)
Proceeds from sale of available-for-sale investments		—				—				—				5,950
Proceeds from maturities of investments		20,550				15,280				107,417				31,801
Acquisition of business, net of cash acquired		—				—				(40,121	)			—
Payment of initial direct costs for operating lease		—				—				(104	)			—
Net cash provided by (used in) investing activities		(934	)			558				(55,648	)			(95,055	)
FINANCING ACTIVITIES
Proceeds from exercise of options		38				274				248				4,738
Taxes paid related to net share settlement of equity awards		(12,638	)			(5,895	)			(55,301	)			(20,784	)
Proceeds from employee stock purchase plan		1,898				1,994				4,693				4,588
Repayments of borrowings		(688	)			(688	)			(2,750	)			(2,749	)
Payment of tax distributions		(3,873	)			(2,149	)			(3,873	)			(2,184	)
Payment of business acquisition holdback liability		(3,905	)			(2,900	)			(4,685	)			(2,900	)
Net cash used in financing activities		(19,168	)			(9,364	)			(61,668	)			(19,291	)
Effect of exchange rate changes on cash and cash equivalents		(2,302	)			813				(1,420	)			785
Change in cash and cash equivalents during the period		(51,344	)			16,100				(44,415	)			(28,959	)
Cash and cash equivalents, beginning of period		228,694				205,665				221,765				250,724
Cash and cash equivalents, end of period	$	177,350			$	221,765			$	177,350			$	221,765
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Cash paid for interest	$	837			$	924			$	3,464			$	3,454
Cash paid for income taxes	$	800			$	395			$	1,979			$	2,432
NON-CASH INVESTING AND FINANCING ACTIVITIES
Purchase of property and equipment included in accounts payable and accrued expense	$	38			$	435			$	38			$	435
Tax distributions payable to Continuing Equity Owners included in accrued expenses	$	23			$	2,945			$	23			$	2,945

Clearwater Analytics Holdings, Inc. Reconciliation of Net Loss to Adjusted EBITDA (In thousands, unaudited)
	Three Months Ended December 31,
	2024							2023
	(in thousands, except percentages)
Net income (loss)	$	420,305			332	%		$	(3,447	)		(3	%)
Adjustments:
Interest income, net		(2,430	)		(2	%)			(1,979	)		(2	%)
Depreciation and amortization		3,451			3	%			2,593			3	%
Equity-based compensation expense and related payroll taxes		30,421			24	%			23,660			24	%
Tax receivable agreement expense		41,637			33	%			8,284			8	%
Transaction expenses		6,382			5	%			441			0	%
Amortization of prepaid management fees and reimbursable expenses		210			0	%			698			1	%
Provision for (benefit from) income taxes		(457,143	)		(361	%)			401			0	%
Other income, net		(1,150	)		(1	%)			(669	)		(1	%)
Adjusted EBITDA		41,683			33	%			29,982			30	%
Revenue	$	126,465			100	%		$	99,019			100	%

	Year Ended December 31,
	2024							2023
	(in thousands, except percentages)
Net income (loss)	$	427,585			95	%		$	(23,083	)		(6	%)
Adjustments:
Interest income, net		(8,621	)		(2	%)			(6,401	)		(2	%)
Depreciation and amortization		12,181			3	%			9,929			3	%
Equity-based compensation expense and related payroll taxes		110,961			25	%			108,078			29	%
Tax receivable agreement expense		53,181			12	%			14,396			4	%
Transaction expenses		8,308			2	%			2,052			1	%
Amortization of prepaid management fees and reimbursable expenses		1,990			0	%			2,592			1	%
Provision for (benefit from) income taxes		(457,648	)		(101	%)			217			0	%
Other income, net		(2,263	)		(1	%)			(1,874	)		(1	%)
Adjusted EBITDA		145,674			32	%			105,906			29	%
Revenue	$	451,803			100	%		$	368,168			100	%

Clearwater Analytics Holdings, Inc. Reconciliation of Free Cash Flow (In thousands, unaudited)
	Three Months Ended December 31,							Year Ended December 31,
		2024				2023			2024			2023
Net cash (used in) provided by operating activities	$	(28,940	)		$	24,093		$	74,321		$	84,602
Less: Purchases of property and equipment		822				1,562			5,259			5,624
Free Cash Flow	$	(29,762	)		$	22,531		$	69,062		$	78,978

Clearwater Analytics Holdings, Inc. Reconciliation of Non-GAAP Information (In thousands, except share amounts and per share amounts, unaudited)
	Three Months Ended December 31,								Year Ended December 31,
		2024				2023				2024				2023
Revenue	$	126,465			$	99,019			$	451,803			$	368,168
Gross profit	$	92,904			$	70,684			$	328,816			$	261,041
Adjustments:
Equity-based compensation expense and related payroll taxes		3,963				3,411				14,546				12,734
Depreciation and amortization		2,840				2,102				10,137				7,999
Gross profit, non-GAAP	$	99,707			$	76,197			$	353,499			$	281,774
As a percentage of revenue, non-GAAP		79	%			77	%			78	%			77	%
Cost of Revenue	$	33,561			$	28,335			$	122,987			$	107,127
Adjustments:
Equity-based compensation expense and related payroll taxes		3,963				3,411				14,546				12,734
Depreciation and amortization		2,840				2,102				10,137				7,999
Cost of revenue, non-GAAP	$	26,758			$	22,822			$	98,304			$	86,394
As a percentage of revenue, non-GAAP		21	%			23	%			22	%			23	%
Research and development	$	40,904			$	33,728			$	150,558			$	123,925
Adjustments:
Equity-based compensation expense and related payroll taxes		11,091				7,394				41,356				25,627
Depreciation and amortization		156				258				736				1,044
Research and development, non-GAAP	$	29,657			$	26,076			$	108,466			$	97,254
As a percentage of revenue, non-GAAP		23	%			26	%			24	%			26	%
Sales and marketing	$	17,885			$	16,316			$	67,254			$	60,365
Adjustments:
Equity-based compensation expense and related payroll taxes		5,024				4,636				16,017				16,419
Depreciation and amortization		173				148				638				589
Sales and marketing, non-GAAP	$	12,688			$	11,532			$	50,599			$	43,357
As a percentage of revenue, non-GAAP		10	%			12	%			11	%			12	%
General and administrative	$	32,896			$	18,050			$	98,770			$	93,496
Adjustments:
Equity-based compensation expense and related payroll taxes		10,343				8,219				39,042				53,298
Depreciation and amortization		282				85				670				297
Amortization of prepaid management fees and reimbursable expenses		210				698				1,990				2,592
Transaction expenses		6,382				441				8,308				2,052
General and administrative, non-GAAP	$	15,679			$	8,607			$	48,760			$	35,258
As a percentage of revenue, non-GAAP		12	%			9	%			11	%			10	%
Income (loss) from operations	$	1,219			$	2,590			$	12,234			$	(16,745	)
Adjustments:
Equity-based compensation expense and related payroll taxes		30,421				23,660				110,961				108,078
Depreciation and amortization		3,451				2,593				12,181				9,929
Amortization of prepaid management fees and reimbursable expenses		210				698				1,990				2,592
Transaction expenses		6,382				441				8,308				2,052
Income from operations, non-GAAP	$	41,683			$	29,982			$	145,674			$	105,906
As a percentage of revenue, non-GAAP		33	%			30	%			32	%			29	%
Net income (loss)	$	420,305			$	(3,447	)		$	427,585			$	(23,083	)
Adjustments:
Equity-based compensation expense and related payroll taxes		30,421				23,660				110,961				108,078
Depreciation and amortization		3,451				2,593				12,181				9,929
Tax receivable agreement expense		41,637				8,284				53,181				14,396
Amortization of prepaid management fees and reimbursable expenses		210				698				1,990				2,592
Transaction expenses		6,382				441				8,308				2,052
Tax impacts of adjustments to net income (loss)(1)		(468,459	)			(8,158	)			(496,779	)			(28,545	)
Net income, non-GAAP	$	33,947			$	24,071			$	117,427			$	85,419
As a percentage of revenue, non-GAAP		27	%			24	%			26	%			23	%
Net income per share - basic, non-GAAP	$	0.15			$	0.12			$	0.54			$	0.43
Net income per share - diluted, non-GAAP	$	0.13			$	0.10			$	0.46			$	0.33
Weighted-average common shares outstanding - basic		226,571,994				206,193,802				219,316,625				199,691,873
Weighted-average common shares outstanding - diluted		258,131,701				252,215,606				254,362,539				255,750,590

(1)

The non-GAAP effective tax rate was 25% for the three months and year ended December 31, 2024 and 2023, respectively, and has been used to adjust the provision for income taxes for non-GAAP net income and non-GAAP basic and diluted net income per share. The Company excludes income tax benefits from discrete activities, including the income tax benefit related to the release of the US federal state valuation allowance, because of their nonrecurring nature.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20250219373514/en/

Investors:

Joon Park | +1 415-906-9242 | investors@clearwateranalytics.com

Media:

Claudia Cahill | +1 703-728-1221 | press@clearwateranalytics.com

Source: Clearwater Analytics Holdings, Inc.

FAQ

What was Clearwater Analytics (CWAN) revenue growth in Q4 2024?

Clearwater Analytics reported Q4 2024 revenue of $126.5 million, representing a 27.7% increase from $99.0 million in Q4 2023.

How much is CWAN paying for the Enfusion acquisition?

Clearwater Analytics announced plans to acquire Enfusion for $1.5 billion to expand its investment management platform with front-to-back capabilities.

What was CWAN's net revenue retention rate in Q4 2024?

Clearwater Analytics achieved a net revenue retention rate of 116% in Q4 2024, up from 107% in Q4 2023.

How much assets does CWAN process daily as of Q4 2024?

As of Q4 2024, Clearwater Analytics processes and reports on $8.8 trillion in assets daily, up from $7.3 trillion in Q4 2023.

What was CWAN's Adjusted EBITDA margin in Q4 2024?

Clearwater Analytics reported an Adjusted EBITDA margin of 33.0% in Q4 2024, an increase of 270 basis points over Q4 2023.